Eiko LifeSciences Limited (BOM:540204)

Market Cap	770.00M +18.7%
Revenue (ttm)	456.37M +31.2%
Net Income	42.41M +208.8%
EPS	3.11 +188.0%
Shares Out	15.16M
PE Ratio	16.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,622
Average Volume	10,138
Open	49.52
Previous Close	48.79
Day's Range	49.52 - 52.96
52-Week Range	46.49 - 65.90
Beta	0.07
RSI	46.08
Earnings Date	May 14, 2026

About Eiko LifeSciences

Eiko LifeSciences Limited, together with its subsidiary, manufactures and sells specialty and fine chemicals in India and internationally. It operates through Agrochemicals; Oleo Chemicals; Pharmaceuticals; Food Additives; Clinical Research, Development; and Logistics segments. It also offers cosmetic emollients, and flavor and fragrances. In addition, the company is involved in manufacturing, suppling, and exporting of specialty chemicals, fine chemicals, and pharma intermediates; acquiring, manufacturing, leasing, and renting, and managing sh...

• Industry: Industrial Organic Chemicals
• Founded: 1977
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540204

Financial Performance

In fiscal year 2025, Eiko LifeSciences's revenue was 376.64 million, an increase of 34.85% compared to the previous year's 279.29 million. Earnings were 21.06 million, an increase of 180.20%.